Bradley Justus Named a National Law Journal Legal Awards Rising Star
August 23, 2024
Axinn partner Bradley Justus has been named a National Law Journal Legal Awards "Rising Star." The National Law Journal Legal Awards highlight the top litigation and appellate work from the previous year, and the attorneys being recognized this year stood out for their work guiding clients through high-stakes litigation.
Bradley Justus's practice focuses on antitrust law, including antitrust litigation, mergers, government investigations, and counseling.
Winners for individual categories with finalists will be unveiled during an awards event on October 24 in Washington D.C.
About Axinn
Axinn combines the skills, experience, and dedication of the world’s largest firms with the focus, responsiveness, efficiency, and attention to client needs of the best boutiques. The firm was established in the late 1990s by lawyers from premier Wall Street firms with a common vision: provide the highest level of service and strategic acumen in antitrust, intellectual property, and high-stakes litigation. Axinn’s lawyers have served as lead or co-lead counsel on more than half a trillion dollars in transactions and, in the last 10 years alone, have handled more than 500 litigations.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
SABA North America Annual Conference 2025
Speaking Engagement
Antitrust
Navigating Compliance: How the 2025 Hart-Scott-Rodino Updates Are Impacting Businesses
Webinar
Antitrust
NJSBA Annual Meeting and Convention 2025
Speaking Engagement
Intellectual Property
Hartford HealthCare Black and Red Gala 2025
Sponsorship
Antitrust
Informa CompLaw Antitrust West Coast Conference 2025
Speaking Engagement
Antitrust
AHLA Health Care Transactions Program 2025
Sponsorship
Antitrust
IAM Live: Auto IP USA 2025
Speaking Engagement
Intellectual Property
ACI 21st Annual Paragraph IV Conference
Speaking Engagement
Intellectual Property
A Check-in on the Structural Presumption: What Have We Learned and Where Are We Headed?
Webinar
Antitrust
Biosimilars Litigation and Client Counseling
Byline Articles